Myocarditis

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
3 Unique IMPs
0 Commercial trials
Drug classes (ATC)
H Endocrinology (ATC H) 2
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Corticosteroid 2 substances
Immunosuppressant 1 substance
Phase III/IV: 1 Phase IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III/IV

1 trial
  • Antwerp University Hospital Academic
    METHYLPREDNISOLONE SODIUM SUCCINATE
    2022-501547-33-01 4 countries 2024 n=205
    Recruiting

Phase IV

1 trial
  • Medical University Of Warsaw Academic
    AZATHIOPRINE; PREDNISONE
    2024-517484-23-00 1 country 2022 n=100
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Antwerp University Hospital Academic 1 Phase III/IV 1
Medical University Of Warsaw Academic 1 Phase IV 1
New trials by year
2022
1
2024
1
← All indication landscapes